Application of mangiferin compound or mango extraction as pancreatic lipase inhibitor and in preparation of medicament or food for preventing and treating obesity
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- HAINAN LIYAOTANG BIOTECH DEV
- Publication Date
- 2015-03-18
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of natural medicines, in particular to the application of mangiferin compounds and / or mango extracts as pancreatic lipase inhibitors and their application in the preparation of medicines and / or foods for treating or preventing obesity. Background technique
[0002] Obesity refers to a certain degree of obvious overweight and thick fat layer, which is a state caused by excessive accumulation of body fat, especially triglycerides. Clinically, obesity is usually divided into three categories: simple obesity, pathological obesity and specific obesity. Among them, simple obesity is divided into: constitutional obesity, which is caused by congenital factors; acquired obesity, which is caused by overeating. The causes of morbid obesity are more complicated, and most of them are hormone secretion disorders caused by some diseases or drugs. Specific obesity mainly includes maternal obesity and postmenopausal obesity. [000...